Renal Anemia: Conflicts and Controversies
Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Dordrecht
Springer Netherlands
2002
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are we using too much intravenous iron in kidney failure patients, and is oral iron supplementation worthless in sustaining iron stores during long-term erythropoietin treatment? When does left ventricular hypertrophy begin to emerge in patients with progressive renal disease and is there convincing evidence that anemia is a significant cause of LVH in this setting? Is darbepoetin alfa, a new novel, long-acting erythropoietin, really superior to recombinant erythropoietin? This book is a compilation of proceedings from a conference in Brooklyn convened to address these and other controversial and unresolved issues in renal anemia management |
| Beschreibung: | 1 Online-Ressource (XI, 145 p) |
| ISBN: | 9789401599986 |
| DOI: | 10.1007/978-94-015-9998-6 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046144629 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s2002 |||| o||u| ||||||eng d | ||
| 020 | |a 9789401599986 |9 978-94-015-9998-6 | ||
| 024 | 7 | |a 10.1007/978-94-015-9998-6 |2 doi | |
| 035 | |a (ZDB-2-SME)978-94-015-9998-6 | ||
| 035 | |a (OCoLC)1119115402 | ||
| 035 | |a (DE-599)BVBBV046144629 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.61 |2 23 | |
| 084 | |a YK 9240 |0 (DE-625)153804:12947 |2 rvk | ||
| 245 | 1 | 0 | |a Renal Anemia |b Conflicts and Controversies |c edited by Onyekachi Ifudu |
| 264 | 1 | |a Dordrecht |b Springer Netherlands |c 2002 | |
| 300 | |a 1 Online-Ressource (XI, 145 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are we using too much intravenous iron in kidney failure patients, and is oral iron supplementation worthless in sustaining iron stores during long-term erythropoietin treatment? When does left ventricular hypertrophy begin to emerge in patients with progressive renal disease and is there convincing evidence that anemia is a significant cause of LVH in this setting? Is darbepoetin alfa, a new novel, long-acting erythropoietin, really superior to recombinant erythropoietin? This book is a compilation of proceedings from a conference in Brooklyn convened to address these and other controversial and unresolved issues in renal anemia management | ||
| 650 | 4 | |a Nephrology | |
| 650 | 4 | |a Hematology | |
| 650 | 4 | |a Internal Medicine | |
| 650 | 4 | |a Transplant Surgery | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Nephrology | |
| 650 | 4 | |a Hematology | |
| 650 | 4 | |a Internal medicine | |
| 650 | 4 | |a Transplantation of organs, tissu | |
| 650 | 4 | |a Diabetes | |
| 650 | 0 | 7 | |a Renale Anämie |0 (DE-588)4177764-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)1071861417 |a Konferenzschrift |y 2001 |z New York, NY |2 gnd-content | |
| 689 | 0 | 0 | |a Renale Anämie |0 (DE-588)4177764-5 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Ifudu, Onyekachi |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789048160457 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781402006784 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401599993 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-94-015-9998-6 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031524814 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1007/978-94-015-9998-6 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180480277348352 |
|---|---|
| any_adam_object | |
| author2 | Ifudu, Onyekachi |
| author2_role | edt |
| author2_variant | o i oi |
| author_facet | Ifudu, Onyekachi |
| building | Verbundindex |
| bvnumber | BV046144629 |
| classification_rvk | YK 9240 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-94-015-9998-6 (OCoLC)1119115402 (DE-599)BVBBV046144629 |
| dewey-full | 616.61 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.61 |
| dewey-search | 616.61 |
| dewey-sort | 3616.61 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-94-015-9998-6 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03213nmm a2200589zc 4500</leader><controlfield tag="001">BV046144629</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s2002 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789401599986</subfield><subfield code="9">978-94-015-9998-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-94-015-9998-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-94-015-9998-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119115402</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144629</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.61</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YK 9240</subfield><subfield code="0">(DE-625)153804:12947</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Renal Anemia</subfield><subfield code="b">Conflicts and Controversies</subfield><subfield code="c">edited by Onyekachi Ifudu</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht</subfield><subfield code="b">Springer Netherlands</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XI, 145 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are we using too much intravenous iron in kidney failure patients, and is oral iron supplementation worthless in sustaining iron stores during long-term erythropoietin treatment? When does left ventricular hypertrophy begin to emerge in patients with progressive renal disease and is there convincing evidence that anemia is a significant cause of LVH in this setting? Is darbepoetin alfa, a new novel, long-acting erythropoietin, really superior to recombinant erythropoietin? This book is a compilation of proceedings from a conference in Brooklyn convened to address these and other controversial and unresolved issues in renal anemia management</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nephrology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Transplant Surgery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nephrology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Transplantation of organs, tissu</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Renale Anämie</subfield><subfield code="0">(DE-588)4177764-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2001</subfield><subfield code="z">New York, NY</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Renale Anämie</subfield><subfield code="0">(DE-588)4177764-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ifudu, Onyekachi</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789048160457</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781402006784</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401599993</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-94-015-9998-6</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524814</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-94-015-9998-6</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)1071861417 Konferenzschrift 2001 New York, NY gnd-content |
| genre_facet | Konferenzschrift 2001 New York, NY |
| id | DE-604.BV046144629 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:26Z |
| institution | BVB |
| isbn | 9789401599986 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524814 |
| oclc_num | 1119115402 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XI, 145 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Springer Netherlands |
| record_format | marc |
| spelling | Renal Anemia Conflicts and Controversies edited by Onyekachi Ifudu Dordrecht Springer Netherlands 2002 1 Online-Ressource (XI, 145 p) txt rdacontent c rdamedia cr rdacarrier Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are we using too much intravenous iron in kidney failure patients, and is oral iron supplementation worthless in sustaining iron stores during long-term erythropoietin treatment? When does left ventricular hypertrophy begin to emerge in patients with progressive renal disease and is there convincing evidence that anemia is a significant cause of LVH in this setting? Is darbepoetin alfa, a new novel, long-acting erythropoietin, really superior to recombinant erythropoietin? This book is a compilation of proceedings from a conference in Brooklyn convened to address these and other controversial and unresolved issues in renal anemia management Nephrology Hematology Internal Medicine Transplant Surgery Diabetes Internal medicine Transplantation of organs, tissu Renale Anämie (DE-588)4177764-5 gnd rswk-swf 1\p (DE-588)1071861417 Konferenzschrift 2001 New York, NY gnd-content Renale Anämie (DE-588)4177764-5 s 2\p DE-604 Ifudu, Onyekachi edt Erscheint auch als Druck-Ausgabe 9789048160457 Erscheint auch als Druck-Ausgabe 9781402006784 Erscheint auch als Druck-Ausgabe 9789401599993 https://doi.org/10.1007/978-94-015-9998-6 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Renal Anemia Conflicts and Controversies Nephrology Hematology Internal Medicine Transplant Surgery Diabetes Internal medicine Transplantation of organs, tissu Renale Anämie (DE-588)4177764-5 gnd |
| subject_GND | (DE-588)4177764-5 (DE-588)1071861417 |
| title | Renal Anemia Conflicts and Controversies |
| title_auth | Renal Anemia Conflicts and Controversies |
| title_exact_search | Renal Anemia Conflicts and Controversies |
| title_full | Renal Anemia Conflicts and Controversies edited by Onyekachi Ifudu |
| title_fullStr | Renal Anemia Conflicts and Controversies edited by Onyekachi Ifudu |
| title_full_unstemmed | Renal Anemia Conflicts and Controversies edited by Onyekachi Ifudu |
| title_short | Renal Anemia |
| title_sort | renal anemia conflicts and controversies |
| title_sub | Conflicts and Controversies |
| topic | Nephrology Hematology Internal Medicine Transplant Surgery Diabetes Internal medicine Transplantation of organs, tissu Renale Anämie (DE-588)4177764-5 gnd |
| topic_facet | Nephrology Hematology Internal Medicine Transplant Surgery Diabetes Internal medicine Transplantation of organs, tissu Renale Anämie Konferenzschrift 2001 New York, NY |
| url | https://doi.org/10.1007/978-94-015-9998-6 |
| work_keys_str_mv | AT ifuduonyekachi renalanemiaconflictsandcontroversies |